Coronavirus Cure Update: According to a Scientists in Australia, HIV and Malaria drugs could be used to fight the coronavirus. At the University of Queensland in Brisbane, an infections disease expert team said they have 2 already existing drugs that can wipe the coronavirus out.
An anti-malaria drug, Chloroquine, and a suppressing HIV combination drugs lopinavir/ritonavir. They have both reportedly shown effective results in humans and the disappearance of the virus in humans.
These drugs are tested as doctors and scientists continue to do more findings to get a cure or vaccine for the deadly coronavirus.
The total number of people affected with the coronavirus globally is above 170,000, and over 6,500 death.
The outbreak of the virus started with china and spread to other countries. With almost 25,000 people infected in Italy, around 14,000 people in Iran, 8,000 people in Spain and more than 5,000 people each in France and Germany.
Professor David Paterson, a researcher in Queensland. Said by the end of the month he will try to start a large scale trial.
HIV Drugs Fails as Potential cure to Coronavirus.
Kaletra, the HIV therapy, gave a drug doctor a high hope, which is gotten from the combinations of lopinavir and ritonavir drugs.
This drug is for people who are affected with HIV. It helps in preventing HIV from developing into AIDS. Also, to reduce the circulation and reproduction of the virus in the body.
Asian Medical Center in Seoul, South Korea. Submitted in the US a clinical trial application. A scientist said: Studies (lab) shows that HIV combined drugs lopinavir/ritonavir has antiviral duties against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
It was reported by the Chinese media that the drugs were used successfully in curing a coronavirus patient. But hasn’t been scientifically proven.
A major blow to the hope of HIV drugs was dealt with by a paper published in the New England Journal.
Several doctors working in china jointly on a paper revealed the combination of the HIV drugs lopinavir/ritonavir. Was more or less no difference from normal care given to an infected patient.
They tried the drugs on 99 patients. And made a comparison with 100 infected patients receiving normal treatment care in the hospital.
It was observed that their recovery was slow, they were not in the chance of dying. But the level of the virus still detectable in their body was similar.
Professor Jonathan Ball, a virus expert at the University of Nottingham, said the results were disappointing, and perhaps not unsurprising.